Apical hypertrophic cardiomyopathy

被引:26
|
作者
Yusuf, Syed Wamique [1 ]
Bathina, Jaya D. [1 ]
Banchs, Jose [1 ]
Mouhayar, Elie N. [1 ]
Daher, Iyad N. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Cardiol, 1515 Holcombe Blvd,Unit 1451, Houston, TX 77030 USA
来源
WORLD JOURNAL OF CARDIOLOGY | 2011年 / 3卷 / 07期
关键词
Apical hypertrophic cardiomyopathy; Electrocardiogram;
D O I
10.4330/wjc.v3.i7.256
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe a patient with asymptomatic apical hypertrophic cardiomyopathy (AHCM) who later developed cardiac arrhythmias, and briefly discuss the diagnostic modalities, differential diagnosis and treatment option for this condition. AHCM is a rare form of hypertrophic cardiomyopathy which classically involves the apex of the left ventricle. AHCM can be an incidental finding, or patients may present with chest pain, palpitations, dyspnea, syncope, atrial fibrillation, myocardial infarction, embolic events, ventricular fibrillation and congestive heart failure. AHCM is frequently sporadic, but autosomal dominant inheritance has been reported in few families. The most frequent and classic electrocardiogram findings are giant negative T-waves in the precordial leads which are found in the majority of the patients followed by left ventricular (LV) hypertrophy. A transthoracic echocardiogram is the initial diagnostic tool in the evaluation of ACHM and shows hypertrophy of the LV apex. AHCM may mimic other conditions such as LV apical cardiac tumors, LV apical thrombus, isolated ventricular non-compaction, endomyocardial fibrosis and coronary artery disease. Other modalities, including left ventriculography, multislice spiral computed tomography, and cardiac magnetic resonance imagings are also valuable tools and are frequently used to differentiate AHCH from other conditions. Medications used to treat symptomatic patients with AHCM include verapamil, beta-blockers and antiarrhythmic agents such as amiodarone and procainamide. An implantable cardioverter defibrillator is recommended for high risk patients. (C) 2011 Baishideng. All rights reserved.
引用
收藏
页码:256 / 259
页数:4
相关论文
共 50 条
  • [1] HYPERTROPHIC APICAL CARDIOMYOPATHY - A SUBTYPE OF HYPERTROPHIC CARDIOMYOPATHY
    ABINADER, EG
    RAUCHFLEISCH, S
    NASCHITZ, J
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1982, 18 (10): : 1005 - 1009
  • [2] APICAL HYPERTROPHIC CARDIOMYOPATHY
    CHIA, BL
    TAN, LK
    AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (09): : 1413 - 1413
  • [3] APICAL HYPERTROPHIC CARDIOMYOPATHY
    KEREIAKES, DJ
    ANDERSON, DJ
    CROUSE, L
    CHATTERJEE, K
    AMERICAN HEART JOURNAL, 1983, 105 (05) : 855 - 856
  • [4] APICAL HYPERTROPHIC CARDIOMYOPATHY
    SMOLDERS, W
    RADEMAKERS, F
    CONRAADS, V
    SNOECK, J
    ACTA CARDIOLOGICA, 1993, 48 (04) : 369 - 383
  • [5] Apical hypertrophic cardiomyopathy
    Ansari, A
    Maron, BJ
    TEXAS HEART INSTITUTE JOURNAL, 1997, 24 (02) : 139 - 139
  • [6] APICAL HYPERTROPHIC CARDIOMYOPATHY
    TOKAREVA, EA
    BORISOVA, GA
    LYAKISHEV, AA
    SAVCHENKO, AP
    KARDIOLOGIYA, 1984, 24 (11) : 122 - &
  • [7] Apical Hypertrophic Cardiomyopathy
    Ho, Anthony M. H.
    Chui, Po T.
    Lee, Alex P. W.
    Wan, Song
    ANESTHESIA AND ANALGESIA, 2015, 121 (05): : 1398 - 1399
  • [8] APICAL HYPERTROPHIC CARDIOMYOPATHY
    GOLD, S
    ERGINA, PL
    FUKUYAMA, O
    AMERICAN HEART JOURNAL, 1989, 118 (06) : 1351 - 1352
  • [9] Apical Hypertrophic Cardiomyopathy
    Abinader, Edward G.
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (10): : 1521 - 1521
  • [10] Apical hypertrophic cardiomyopathy
    Ortiz, Guillermo A.
    Rodriguez Acuna, Maria
    Boskis, Pablo F.
    REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2012, 41 (01): : 57 - 58